Is Boundless Bio, Inc. (BOLD) a Buy, Sell, or Hold?
NASDAQ : BOLD
Boundless Bio, Inc.
$2.51 USD
$0.04 (1.62%)
- Volume
- 137.71K
- Average Volume
- 1.26M
- Market Capitalization
- $56.41M
- P/E Ratio
- -0.99
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.79
- Year Low
- $0.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.87
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
33
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
4
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$64000
BOLD Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
BOLD Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| TANG KEVIN | 10 percent owner | 2026-07-13 | P-Purchase | 2.42 | 2026-07-13 |
| TANG KEVIN | 10 percent owner | 2026-07-10 | P-Purchase | 2.43 | 2026-07-13 |
| TANG KEVIN | 10 percent owner | 2026-07-09 | P-Purchase | 2.48 | 2026-07-13 |
| TANG KEVIN | 10 percent owner | 2026-07-08 | P-Purchase | 2.46 | 2026-07-08 |
| TANG KEVIN | 10 percent owner | 2026-07-07 | P-Purchase | 2.48 | 2026-07-08 |
| TANG KEVIN | 10 percent owner | 2026-07-06 | P-Purchase | 2.49 | 2026-07-08 |
| CRANDELL KEITH | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| CRANDELL KEITH | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| CRANDELL KEITH | 10 percent owner | 2026-07-01 | S-Sale | 2.49 | 2026-07-06 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | 2026-07-01 | S-Sale | 2.49 | 2026-07-06 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | 2026-07-01 | M-Exempt | 1.03 | 2026-07-06 |
| TANG KEVIN | 10 percent owner | 2026-07-02 | P-Purchase | 2.49 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-07-01 | P-Purchase | 2.49 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-06-30 | P-Purchase | 2.5 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-06-30 | P-Purchase | 2.54 | 2026-07-02 |
| TANG KEVIN | 10 percent owner | 2026-06-29 | P-Purchase | 2.48 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-29 | P-Purchase | 2.47 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-26 | P-Purchase | 2.54 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-26 | P-Purchase | 2.55 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-25 | P-Purchase | 2.56 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-25 | P-Purchase | 2.48 | 2026-06-29 |
| TANG KEVIN | 10 percent owner | 2026-06-25 | 0 | 2026-06-29 | |
| Whiting Nancy | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Lim Jonathan E | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Christensen James | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Lew Jennifer | director | 2026-06-15 | A-Award | 1.4 | 2026-06-15 |
| Oien Jessica | officer: See Remarks | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Hassig Christian | officer: Chief Scientific Officer | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Doebele Robert | officer: Chief Medical Officer | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Hornby Zachary | director, officer: President & CEO | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| HINKLE DAVID A | officer: See Remarks | 2026-01-23 | A-Award | 1.26 | 2026-01-26 |
| Brennan Christine | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Christensen James | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Lew Jennifer | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Lim Jonathan E | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Burow Kristina | director, 10 percent owner: | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Whiting Nancy | director | 2025-06-23 | A-Award | 1.03 | 2025-06-23 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-15 | U-Tender | 60 | 2020-01-15 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-15 | D-Return | 2.7649 | 2020-01-15 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-15 | D-Return | 15.26 | 2020-01-15 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-15 | D-Return | 27.39 | 2020-01-15 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-15 | D-Return | 9.4988 | 2020-01-15 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-15 | D-Return | 24.74 | 2020-01-15 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-15 | D-Return | 15.26 | 2020-01-15 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-15 | D-Return | 27.39 | 2020-01-15 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-15 | D-Return | 24.74 | 2020-01-15 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-15 | D-Return | 9.4988 | 2020-01-15 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-15 | U-Tender | 60 | 2020-01-15 |
| Holles Natalie C. | officer: President and COO | 2020-01-15 | D-Return | 27.39 | 2020-01-15 |
| Holles Natalie C. | officer: President and COO | 2020-01-15 | D-Return | 36.39 | 2020-01-15 |
| Holles Natalie C. | officer: President and COO | 2020-01-15 | D-Return | 24.74 | 2020-01-15 |
| Holles Natalie C. | officer: President and COO | 2020-01-15 | D-Return | 9.4988 | 2020-01-15 |
| Holles Natalie C. | officer: President and COO | 2020-01-15 | U-Tender | 60 | 2020-01-15 |
| Holles Natalie C. | officer: President and COO | 2020-01-15 | D-Return | 2.7649 | 2020-01-15 |
| Holles Natalie C. | officer: President and COO | 2020-01-15 | D-Return | 15.26 | 2020-01-15 |
| Goldberg Mark Alan | director | 2020-01-15 | U-Tender | 60 | 2020-01-15 |
| Goldberg Mark Alan | director | 2020-01-15 | D-Return | 24.74 | 2020-01-15 |
| Goldberg Mark Alan | director | 2020-01-15 | D-Return | 33.91 | 2020-01-15 |
| Goldberg Mark Alan | director | 2020-01-15 | D-Return | 38 | 2020-01-15 |
| Goldberg Mark Alan | director | 2020-01-15 | D-Return | 38.65 | 2020-01-15 |
| Conner Edward R. | officer: SVP, Chief Medical Officer | 2020-01-15 | D-Return | 36.08 | 2020-01-15 |
| Conner Edward R. | officer: SVP, Chief Medical Officer | 2020-01-15 | U-Tender | 60 | 2020-01-15 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-08 | M-Exempt | 15.26 | 2020-01-10 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-08 | M-Exempt | 2.7649 | 2020-01-10 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-08 | M-Exempt | 15.26 | 2020-01-10 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2020-01-08 | M-Exempt | 2.7649 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 15.26 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 9.5 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 2.19 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 15.26 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 0.78 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 9.5 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2019-12-26 | G-Gift | 0 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 2.19 | 2020-01-10 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2020-01-08 | M-Exempt | 0.78 | 2020-01-10 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2019-12-12 | M-Exempt | 2.7649 | 2019-12-16 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2019-12-12 | M-Exempt | 2.7649 | 2019-12-16 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2019-12-12 | F-InKind | 59.37 | 2019-12-16 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2019-12-12 | F-InKind | 59.37 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 24.74 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 27.39 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 15.26 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 2.7649 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | F-InKind | 59.37 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 9.4988 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 27.39 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 2.7649 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 24.74 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | F-InKind | 59.37 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 15.26 | 2019-12-16 |
| Holles Natalie C. | officer: President and COO | 2019-12-12 | M-Exempt | 9.4988 | 2019-12-16 |
| Conner Edward R. | officer: SVP, Chief Medical Officer | 2019-12-12 | F-InKind | 59.37 | 2019-12-16 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2019-12-05 | F-InKind | 59.21 | 2019-12-09 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2019-12-05 | F-InKind | 59.21 | 2019-12-09 |
| Holles Natalie C. | officer: President and COO | 2019-12-05 | F-InKind | 59.21 | 2019-12-09 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2019-11-08 | M-Exempt | 9.5 | 2019-11-12 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2019-11-08 | M-Exempt | 9.5 | 2019-11-12 |
| Patterson Matthew R | director, officer: Chief Executive Officer | 2019-11-08 | S-Sale | 30 | 2019-11-12 |
| Soloway Thomas P | officer: Executive Vice President, CFO | 2019-09-05 | F-InKind | 31.02 | 2019-09-09 |